casein kinase-1delta inhibitors (Centro de Investigaciones Biologicas)

N/A

Report date: 2025/03/14 16:43:23
NME

Base Information

Drug Namecasein kinase-1delta inhibitors (Centro de Investigaciones Biologicas)
Drug Alias NameIGS-3.27IGS-2.7casein kinase-I delta inhibitor (Centro Investigaciones Biologicas)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase I isoform delta inhibitors
TargetsCasein kinase I isoform delta
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentro de investigaciones biologicas
China Registration ClassN/A

Develop Information

Active CompaniesCentro de investigaciones biologicas
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A